The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Boston Trust Walden Corp raised its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 1,490.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,100 shares of the medical research company's stock after buying an additional 37,578 shares during the

Valley National Advisers Inc. lowered its position in Thermo Fisher Scientific Inc. (NYSE: TMO) by 92.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 254 shares of the medical research company's stock after selling 3,028 shares during the

HBK Sorce Advisory LLC lessened its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 16.8% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 7,498 shares of the medical research company's stock after selling 1,512 shares during the period. HBK Sorce Advisory LLC's holdings

Carnegie Investment Counsel cut its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 5.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 49,645 shares of the medical research company's stock after selling 2,768 shares during the quarter. Carnegie Investment

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2025 before the market opens on Thursday, January 29, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the “Investors” section of our websit.

Farther Finance Advisors LLC increased its position in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 17.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,688 shares of the medical research company's stock after buying an additional 1,144 shares during

Coho Partners Ltd. cut its position in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 43.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 69,551 shares of the medical research company's stock after selling 53,070 shares during the quarter. Thermo

Thermo Fisher launches a global PPD CorEvitas Alzheimer's registry, enrolling its first patient to generate real-world safety and effectiveness data.

Traditions are a core part of the Christmas experience and, for this Proactive Investors journalist, one of these is the annual stock-picking competition. A...